Ames (df) dwarf mice provide an entree for understanding the molecular events that regulate pituitary gland organogenesis. Mutants exhibit panhypopituitarism, or multiple pituitary hormone deficiency, failing to produce adequate amounts of prolactin, growth hormone, thyroid stimulating hormone, or gonadotropins. A missense mutation in the homeodomain of the transcription factor Propi is responsible for the defect. This partial loss of function mutation affects development of the pituitary gland early in organogenesis, causing cytodifferentiation failure of several cell types that ultimately results in a hypocellular anterior pituitary lobe. PROP1 mutations cause multiple pituitary hormone deficiency in humans as well, although the phenotype is variable, occasionally involving loss of adrenocorticotropin production. Using genetic engineering in mice we generated both null and gain of function alleles of Prop. Homozygotes for the null allele exhibit lethality with 50% penetrance, which may result from adrenal insufficiency, as observed in some human pedigrees with PROP1 mutations. Propi expression is normally restricted to a short window of pituitary development, and prolonged expression causes transient hypogonadism and delayed puberty due to delayed differentiation of pituitary gonadotropin producing cells. In addition, mice with this gain of function allele develop adult onset hypothyroidism and have increased risk of pituitary adenomas. Pituitary adenomas are the most common type of intracranial tumor in humans, although little is known about the genetic changes that lead to adenoma formation. We have delineated many of the sequential steps in the commitment process of organogenesis, placing Prop 1 in the genetic hierarchy relative to several other critical homeobox genes. During the next grant cycle we propose to characterize the Propi null allele to discover the basis for the failure of cytodifferentiation. We will dissect the interactions of Propi with pituitary transcription factors and secreted signaling molecules that are important in early development using genetics, explant and cell culture, DNA sequence analysis, and differential expression analysis. These studies will expand our understanding of pituitary organogenesis and tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37HD030428-10
Application #
6547772
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Javois, Lorette Claire
Project Start
1993-04-01
Project End
2007-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
10
Fiscal Year
2002
Total Cost
$317,856
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Genetics
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Pérez Millán, María I; Vishnopolska, Sebastian A; Daly, Alexandre Z et al. (2018) Next generation sequencing panel based on single molecule molecular inversion probes for detecting genetic variants in children with hypopituitarism. Mol Genet Genomic Med :
Cheung, Leonard Y M; Davis, Shannon W; Brinkmeier, Michelle L et al. (2017) Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways. Mol Cell Endocrinol 445:14-26
Fang, Qing; Benedetti, Anna Flavia Figueredo; Ma, Qianyi et al. (2016) HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype. Clin Endocrinol (Oxf) 85:408-14
Fang, Qing; George, Akima S; Brinkmeier, Michelle L et al. (2016) Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era. Endocr Rev 37:636-675
Brinkmeier, Michelle L; Geister, Krista A; Jones, Morgan et al. (2015) The Histone Methyltransferase Gene Absent, Small, or Homeotic Discs-1 Like Is Required for Normal Hox Gene Expression and Fertility in Mice. Biol Reprod 93:121
Jones, Morgan; Chase, Jennifer; Brinkmeier, Michelle et al. (2015) Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. J Clin Invest 125:2007-20
Castinetti, F; Brinkmeier, M L; Mortensen, A H et al. (2015) ISL1 Is Necessary for Maximal Thyrotrope Response to Hypothyroidism. Mol Endocrinol 29:1510-21
Mortensen, Amanda H; MacDonald, James W; Ghosh, Debashis et al. (2011) Candidate genes for panhypopituitarism identified by gene expression profiling. Physiol Genomics 43:1105-16
Camper, Sally A (2011) Beta-catenin stimulates pituitary stem cells to form aggressive tumors. Proc Natl Acad Sci U S A 108:11303-4
Castinetti, Frederic; Davis, Shannon W; Brue, Thierry et al. (2011) Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev 32:453-71

Showing the most recent 10 out of 49 publications